Day: December 2, 2019

RioCan Real Estate Investment Trust Announces Date of Fourth Quarter 2019 Earnings Release, Conference Call and Webcast

Written by Customer Service on December 2, 2019. Posted in Public Companies.

TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX:REI.UN) today announced that it is scheduled to release its financial results for the three months and year-ended December 31, 2019 before the market opens on Thursday, February 20, 2020.Interested parties are invited to participate in a conference call with management on Thursday, February 20, 2020 at 10:00 a.m. Eastern time. You will be required to identify yourself and the organization on whose behalf you are participating.In order to participate, please dial 647-427-3230 or 1-877-486-4304. If you cannot participate in the live mode, a replay will be available. To access the replay, please dial 1-855-859-2056 and enter the passcode 7578658#.Alternatively, to access the simultaneous webcast, go to the following link on RioCan’s website...

Microbix Invited to Present Product Results at HPV Congress

Written by Customer Service on December 2, 2019. Posted in Public Companies.

MISSISSAUGA, Ontario, Dec. 02, 2019 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces it has been invited to present the performance of its in-vitro diagnostics (IVD) quality products “IVD Controls” at EUROGIN 2019, the annual congress of the European Research Organization on Genital Infection & Neoplasia.At EUROGIN, Microbix will be exhibiting alongside leading IVD and pharmaceutical companies working on prevention and detection of Human Papilloma Virus (HPV) infection. The majority of sexually-active adults are infected with one or more types of HPV and the high-risk variants of the virus are a well-known and common cause of multiple...

LiteLink Technologies Issues Letter to Shareholders

Written by Customer Service on December 2, 2019. Posted in Public Companies.

VANCOUVER, British Columbia, Dec. 02, 2019 (GLOBE NEWSWIRE) — LiteLink Technologies Inc. (“LiteLink”) (CSE:LLT) (OTC:LLNKF) (FRA:C0B), a key player in logistics platforms and payment solutions, is pleased to provide the following letter to shareholders from LiteLink Chief Executive Officer Ashik Karim.Dear Shareholders,It is my honor to write my first letter to you as chief executive of LiteLink Technologies Inc. (LiteLink), following a year of innovation, market expansion and exciting growth. We are staying true to our mission and core values that we have built at LiteLink over the past 18 months. 2019 was a building period both from a products and customer trust perspective, with many intentional and impactful moves. We navigated through two major industries experiencing profound disruption in business behavior. 1SHIFT in 2019...

Generation Mining Significantly Increases Mineral Resource at the Marathon Palladium Property

Written by Customer Service on December 2, 2019. Posted in Public Companies.

TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Generation Mining Limited (CSE:GENM) (“Gen Mining” or the “Company”) is pleased to announce an increase in the Mineral Resource Estimate for its Marathon Palladium property in Northwestern Ontario. The new estimate reflects a comprehensive review of the past drilling completed by the previous operators on the Geordie and Sally deposits which are both located on the Company’s Marathon Property and within 16 km of the Marathon Deposit, which contains an estimated 7.1 million palladium equivalent ounces Mineral Resources in the Measured and Indicated classification.HighlightsThe new estimates add 1,568,000 of palladium equivalent (“PdEq”) ounces of Mineral Resources to the Property in the Indicated classification, bringing the Property total Measured and Indicated Mineral Resources to 8,668,000...

GBT Seeks to Develop New Microchip Architectures Aimed at Expanding AI Market Opportunities

Written by Customer Service on December 2, 2019. Posted in Public Companies.

SANTA MONICA, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), a company specializing in the development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including its GopherInsight™ wireless mesh network technology platform and its Avant! AI, for both mobile and fixed solutions, announced new microchip architectures aimed at expanding GBT’s AI go-to-market strategy.The new architectures, now in development, are targeted to leverage world-class, on-chip AI technologies for the benefit of IC design houses.GBT is focusing on advanced manufacturing processes for the creation of industry-leading electronic products. The Company plans to continue its IC scaling in order to achieve high silicon transistor density while...

Orchard Therapeutics Announces the Filing and Validation of Marketing Authorization Application by European Medicines Agency for OTL-200 for the Treatment of Metachromatic Leukodystrophy

Written by Customer Service on December 2, 2019. Posted in Public Companies.

BOSTON and LONDON, Dec. 02, 2019 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced that the European Medicines Agency (EMA) has validated the company’s Marketing Authorization Application (MAA) for OTL-200, an ex vivo, autologous, hematopoietic stem cell-based gene therapy that has been developed in partnership with the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, for the treatment of metachromatic leukodystrophy (MLD). Validation of the MAA confirms that the submission is sufficiently complete to begin the formal review process.“We are pleased that OTL-200 for the treatment of MLD is now under review...

Invesco Ltd.: Form 8.3 – Redde PLC

Written by Customer Service on December 2, 2019. Posted in Mergers And Acquisitions.

Opening Position DisclosureFORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant...

ChromaDex Receives Approval for Nicotinamide Riboside Chloride as an Ingredient for Complementary Medicines from the Australian Therapeutic Goods Administration (TGA)

Written by Customer Service on December 2, 2019. Posted in Public Companies.

LOS ANGELES, Dec. 02, 2019 (GLOBE NEWSWIRE) — ChromaDex Corp. (NASDAQ:CDXC) today announced that it has received approval from the Australian Therapeutic Goods Administration (TGA) for its patented nicotinamide riboside chloride (NR) for use in listed complementary medicines. The listing indicates that ChromaDex has market exclusivity of NR through December 2, 2021.With this approval, ChromaDex will be listing their final product as a complementary medicine on the Australian Register of Therapeutic Goods (ARTG).“This is an important milestone as we expand our presence in the Asia-Pacific region,” says ChromaDex CEO Rob Fried. “We look forward to sharing the unparalleled science behind our ingredient with the people of Australia in 2020.”Cells can use NR to create nicotinamide adenine dinucleotide (NAD), which is an essential molecule...

Enthusiast Gaming Announces Pro Forma Revenue of $6.3 Million in Third Quarter 2019

Written by Customer Service on December 2, 2019. Posted in Public Companies.

Completes mergers of Enthusiast Gaming, Aquilini GameCo, and Luminosity Gaming in Q3 to create leading publicly traded esports and gaming organization Filed interim financial statements for the three and nine month periods ending September 30, 2019, with revenue of $3.0 million being reported relating to the post merger period of August 27 to September 30, 2019Assuming the completion of the Enthusiast, Aquilini GameCo, and Luminosity Gaming mergers retrospectively to July 1, 2019, pro forma revenue for Q3 2019 would be $6.3 millionAchieves pro forma consolidated gross margins of 49% in the quarterCompletes the funding of the Deferred Payment on “The Sims Resource” acquisition, seven months ahead of scheduleTORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (TSXV: EGLX) (FSE: 2AV) (“Enthusiast Gaming”...

Uxin Announces the Resignation of Chief Strategy Officer

Written by Customer Service on December 2, 2019. Posted in Public Companies.

BEIJING, Dec. 02, 2019 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading national online used car dealer in China, today announced that Mr. Wenbing Jing has resigned as the Company’s Chief Strategy Officer, effective December 1, 2019, for personal reasons. During his tenure with the Company, Mr. Jing mainly oversaw the Company’s loan facilitation business, which is currently in the process of being divested as announced by the Company in July, September and November 2019.Mr. Kun Dai, Founder, Chairman and Chief Executive Officer of Uxin, said, “Wenbing has been a long-time friend and trusted partner and helped drive the fast growth of our business over the past several years. We sincerely appreciate Wenbing’s contributions and dedication to the Company and wish him the best in his future endeavors.”About...

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Day: December 2, 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals